March 9, 2026 · Arthritis & rheumatology (Hoboken, N.J.) · DOI: 10.1002/art.70128

Immune checkpoint inhibitor-associated inflammatory arthritis

Listen to this summary

The authors aim to elucidate the mechanisms underlying immune checkpoint inhibitor-associated inflammatory arthritis (ICI-IA), which occurs in approximately 6% of patients receiving ICI cancer therapy and resembles rheumatoid arthritis. They discuss the cellular characteristics of ICI-IA, including the role of specific T cell and macrophage populations, and suggest that understanding ICI-IA may provide insights into the biology of other inflammatory arthritis forms. The review highlights current knowledge and proposes future research directions in this area.

Sang T Kim, Anne R Bass

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play